Giant Cell Arteritis (and PMR) Q&A скачать в хорошем качестве

Giant Cell Arteritis (and PMR) Q&A

0:00 2:20 Is there an eye exam that can identify early signs of restricted blood loss that could lead to optic nerve damage to intervene to prevent vision loss? 8:38 Q: Can GCA spread into the aorta or femoral arteries? 10:48 Q: My daughter was diagnosed yesterday with LVV and possibly GCA. She is 31. Doesn’t that seem too young for that diagnosis? 13:03 Q: You covered many of the current GCA trials underway in our January webinar. Could you give us any updates or noteworthy developments from any of those studies and clinical trials? 13:22 Q: Exciting news about the Select GSA Phase 3 Study (Rinvoq) 17:44 Q: Can you give a patient-level explanation about Polymyalgia rheumatica (PMR)? 20:37 Q: How often can patients with PMR develop GCA? 22:17 Q: Are there any studies or clinical trials underway for PMR? 23:58 Q: Are there risk factors associated with PMR if it progresses without treatment? 26:20 Q: What is a neuro-ophthalmologist? How do they differ from an ophthalmologist in terms of management and/or diagnosis of GCA? 28:16 Q: Could you explain VEXAS Syndrome? Q&A: Giant Cell Arteritis (GCA) and Polymyalgia rheumatica (PMR) Recorded August 2024